KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

GoodRx Holdings (GDRX) Net Margin (2019 - 2026)

GoodRx Holdings' Net Margin history spans 7 years, with the latest figure at 2.79% for Q4 2025.

  • On a quarterly basis, Net Margin fell 61.0% to 2.79% in Q4 2025 year-over-year; TTM through Dec 2025 was 3.82%, a 175.0% increase, with the full-year FY2025 number at 3.82%, up 175.0% from a year prior.
  • Net Margin hit 2.79% in Q4 2025 for GoodRx Holdings, up from 0.57% in the prior quarter.
  • Over the last five years, Net Margin for GDRX hit a ceiling of 30.99% in Q2 2023 and a floor of 22.28% in Q3 2022.
  • Historically, Net Margin has averaged 0.47% across 5 years, with a median of 0.81% in 2021.
  • Biggest five-year swings in Net Margin: soared 18265bps in 2021 and later tumbled -2766bps in 2024.
  • Tracing GDRX's Net Margin over 5 years: stood at 18.72% in 2021, then skyrocketed by 94bps to 1.07% in 2022, then crashed by -1128bps to 13.16% in 2023, then skyrocketed by 126bps to 3.39% in 2024, then fell by -18bps to 2.79% in 2025.
  • Business Quant data shows Net Margin for GDRX at 2.79% in Q4 2025, 0.57% in Q3 2025, and 6.32% in Q2 2025.